Insecticides (India) Limited (NSE:INSECTICID)
India · Delayed Price · Currency is INR 547.50
+6.20 (1.15%)
Nov 11, 2026, 2:30 PM IST
Insecticides (India) Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 21,090 | 21,400 | 19,999 | 19,664 | 18,013 | 15,040 |
Other Revenue | 86.72 | 86.72 | 3.45 | 0.28 | - | - |
| 21,177 | 21,487 | 20,003 | 19,664 | 18,013 | 15,040 | |
Revenue Growth | 3.51% | 7.42% | 1.72% | 9.16% | 19.77% | 5.90% |
Cost of Revenue | 14,446 | 14,785 | 13,775 | 14,765 | 13,933 | 11,132 |
Gross Profit | 6,731 | 6,702 | 6,228 | 4,899 | 4,080 | 3,908 |
Selling, General & Admin | 2,312 | 2,186 | 1,919 | 1,495 | 1,082 | 916.34 |
Other Operating Expenses | 2,086 | 2,042 | 2,090 | 1,779 | 1,670 | 1,268 |
Operating Expenses | 4,783 | 4,583 | 4,304 | 3,568 | 3,016 | 2,461 |
Operating Income | 1,949 | 2,118 | 1,924 | 1,331 | 1,064 | 1,446 |
Interest Expense | -189.26 | -155.29 | -48.73 | -91.98 | -112.83 | -49.76 |
Interest & Investment Income | 5.21 | 5.21 | 25.83 | 25.69 | 3.21 | 5.88 |
Earnings From Equity Investments | 2.45 | 2.97 | 5.75 | 3.1 | 2.32 | 4.07 |
Currency Exchange Gain (Loss) | -116.15 | -116.15 | 27.69 | 39.75 | -105.98 | 17.04 |
Other Non Operating Income (Expenses) | -13.07 | 4.02 | -9.54 | -9.82 | -13.59 | 2.7 |
EBT Excluding Unusual Items | 1,638 | 1,859 | 1,925 | 1,298 | 837.62 | 1,426 |
Gain (Loss) on Sale of Investments | 2.48 | 2.48 | 0.52 | 0.5 | - | - |
Gain (Loss) on Sale of Assets | 4.41 | 4.41 | 1.91 | 17.32 | -0.67 | -12.92 |
Other Unusual Items | 0.74 | 0.74 | 0.18 | 3.38 | 1.33 | 0.52 |
Pretax Income | 1,646 | 1,867 | 1,928 | 1,319 | 838.29 | 1,414 |
Income Tax Expense | 423.1 | 472.68 | 507.51 | 298.14 | 206.18 | 339.44 |
Net Income | 1,222 | 1,394 | 1,420 | 1,021 | 632.11 | 1,074 |
Net Income to Common | 1,222 | 1,394 | 1,420 | 1,021 | 632.11 | 1,074 |
Net Income Growth | -17.66% | -1.84% | 39.13% | 61.48% | -41.16% | 14.40% |
Shares Outstanding (Basic) | 29 | 29 | 29 | 30 | 30 | 30 |
Shares Outstanding (Diluted) | 29 | 29 | 29 | 30 | 30 | 30 |
Shares Change | -0.02% | -0.87% | -0.82% | - | -0.34% | -4.21% |
EPS (Basic) | 42.01 | 47.91 | 48.38 | 34.49 | 21.36 | 36.17 |
EPS (Diluted) | 42.01 | 47.91 | 48.38 | 34.49 | 21.36 | 36.17 |
EPS Growth | -17.65% | -0.97% | 40.28% | 61.48% | -40.96% | 19.43% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 940.86 | 56.55 | 561.68 | 1,379 | -980.91 | 675.7 |
Free Cash Flow Per Share | 32.34 | 1.94 | 19.14 | 46.61 | -33.14 | 22.75 |
Dividend Per Share | - | 2.000 | 2.000 | 3.000 | 3.000 | 2.000 |
Dividend Growth | - | 0% | -33.33% | 0% | 50.00% | 50.00% |
Gross Margin | 31.79% | 31.19% | 31.14% | 24.92% | 22.65% | 25.98% |
Operating Margin | 9.20% | 9.86% | 9.62% | 6.77% | 5.91% | 9.62% |
Profit Margin | 5.77% | 6.49% | 7.10% | 5.19% | 3.51% | 7.14% |
Free Cash Flow Margin | 4.44% | 0.26% | 2.81% | 7.02% | -5.45% | 4.49% |
EBITDA | 2,298 | 2,438 | 2,187 | 1,598 | 1,302 | 1,687 |
EBITDA Margin | 10.85% | 11.35% | 10.93% | 8.13% | 7.22% | 11.21% |
D&A For EBITDA | 349.16 | 319.58 | 263.11 | 266.87 | 237.03 | 240.32 |
EBIT | 1,949 | 2,118 | 1,924 | 1,331 | 1,064 | 1,446 |
EBIT Margin | 9.20% | 9.86% | 9.62% | 6.77% | 5.91% | 9.62% |
Effective Tax Rate | 25.71% | 25.32% | 26.33% | 22.61% | 24.59% | 24.01% |
Revenue as Reported | 21,190 | 21,517 | 20,069 | 19,758 | 18,026 | 15,082 |
Advertising Expenses | - | 521.12 | 525.37 | 314.81 | 94.23 | 46.74 |